Elevated NGF levels are observed in chronic pain states (e.g., osteoarthritis, intervertebral disk degeneration), and in humans, an anti-NGF antibody (tanezumab) produced significant analgesia in clinical trials of osteoarthritis and chronic back pain [22]. This evidence concerns the gene NGF and osteoarthritis.